Get to know our innovation community as we find solutions together.

502

ClavystBio Conversations:

The Growing Pains of Getting a Product Into Clinic

Hummingbird Bioscience CEO Piers Ingram and MediSix Therapeutics CEO Andrew Bruce discuss their experiences and the different paths their companies have taken to bring their leads assets into the clinic and ultimately patients globally.

Posted on 11 Sep 2023

477

ClavystBio Conversations:

Building a Biotech Company Across Two Continents

Allay Therapeutics CEO Adam Gridley and Engine Biosciences CEO Jeffrey Lu discuss the value in creating a global company, working across the US and Singapore.

Posted on 10 Jan 2023

398

ClavystBio Conversations:

The Chemistry of Academia and Industry

CoVBio CSO Prof Wang Linfa and CEO Dr Rosemary Tan discuss their partnership and what makes it successful.

Posted on 01 Dec 2022